Last reviewed · How we verify
Vapocoolant spray
At a glance
| Generic name | Vapocoolant spray |
|---|---|
| Also known as | Cryoanesthetic, PainEase™, Gebauer's Pain Ease, Numbing Spray, 1,1,1,3,3-Pentafluoropropane |
| Sponsor | Tehran University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Vapocoolant Spray to Reduce Pain With Nexplanon Insertion (NA)
- Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement (PHASE3)
- Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures (PHASE4)
- Cryotherapy on Muscle Function (NA)
- Vapocoolant Analgesia for Breast Lymphoscintigraphy (NA)
- Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray (PHASE4)
- Comparison of Lidocaine-Prilocaine Combination and Vapocoolant for IV Cannulation Pain in the ED (PHASE3)
- Vapocoolant Spray Application During Intraarticular Knee Injection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vapocoolant spray CI brief — competitive landscape report
- Vapocoolant spray updates RSS · CI watch RSS
- Tehran University of Medical Sciences portfolio CI